DRUG ABUSE MANIFESTING AS PERSISTENT HYPOGLYCEMIA:
A CASE REPORT OF HIDDEN SULFONYLUREA POISONING
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Background

Case Report

Discussion

• Prescription drug abuse is on the rise. According to the Philadelphia
Department of Health data in 2017, up to 26% of adults may be using
benzodiazepines and/or opioids (Table 1).

History of Present Illness: A 45-year-old man with no significant past
medical history presented with confusion, diaphoresis and weakness of two
days duration. Vitals were significant for tachycardia to 115 and high blood
pressures to 220/110. Physical exam showed an anxious, diaphoretic male
in mild distress. Point-of-care accuchecks revealed hypoglycemia into the
30s. Despite multiple amps of glucose, he remained hypoglycemic so was
started on a D5W, then D10W infusion. He admitted to snorting heroin and
taking Xanax (alprazolam); both were obtained from the streets with last
use 1.5 days prior to admission. He denied taking any other medications.

• Hypoglycemia is a dangerous condition that is fatal if left untreated. It
can be due to exogenous insulin overdose, sulfonylurea (SU) overdose, or
the presence of an insulinoma.

Labs: Urine drug screen revealed cocaine, opioids, and benzodiazepines.
On admission, his insulin levels were found to be abnormally elevated (up
to 27 mIU/L). He also had an elevated proinsulin (50.1 pmol/L), normal cpeptide (2.90 ng/mL), and normal beta-hydroxybutyrate (0.6 mmol/L). His
HgA1C was 5.8%.

• Lab abnormalities (insulin, proinsulin and c-peptide levels) can look
similar in an insulinoma or a patient who has overdosed on SUs. The
difference is in the SU level. A patient who otherwise has no risk factors
should still be worked up for an insulinoma if they remain persistently
hypoglycemic after several days of unknown substance ingestion.

Imaging: Abdominal MRI revealed no evidence of insulinoma.

• Our patient’s sulfonylurea screen revealed elevated glipizide levels (120
ng/mL) several days after presumed ingestion with ‘Xanax.’ Given no
prior history of liver or kidney disease, it was unusual for him to remain
persistently hypoglycemic several days after the ingestion. His blood
glucose levels eventually improved off glucose supplementation. The
persistent hypoglycemia was likely due to the large amount of SUs mixed
into the ‘ Xanax ‘ he was buying.

• 12% or 1/8 Philadelphians are estimated to be current benzodiazepine
users and have taken one in the last 7 days. Benzodiazepine use is most
common among people with household incomes below $25,000 and
among the 45-54 years old age group (17.7%) [1].
• Most current users (84%) obtain benzodiazepines from health care
providers [1]. However, with new policies to closely monitor controlled
substances, those with dependence on benzodiazepines may turn to
alternative sources (such as black market vendors) to obtain the drug.
• Street-obtained versions may be substituted or mixed with alternative
products to maximize profits for vendors. Unsuspecting users can be
subject to life-threatening side effects.
• To clinicians caring for these patients, the composition of
benzodiazepines obtained outside of a pharmacy may not easily be
identifiable, making treating intoxications a challenge.

Table 1: Philadelphia Department of Public Health
2017 Estimates of Current Opioid and Benzodiazepine
Adult Users
Substance
Benzodiazepine Use Only
Opioid Use
Opioid Use Only
Opioid + Benzodiazepine Use
No Opioid or Benzodiazepine Use
Total Population

Estimated Number of Current
Philadelphia Adult Users
92,000
168,000
106,000
62,000
1,208,000
1,636,000

Hospital Course: The patient’s blood glucose fluctuated during the initial
period of his hospitalization. He was intermittently hypoglycemic even
several days in, with an episode to 55 mg/dL around noon on hospital day
5. There was no identifiable postprandial correlation. Eventually, his blood
glucose stabilized with supportive care only; D10W was weaned off without
further hypoglycemic episodes. His sulfonylurea screen came back positive
for a high level of glipizide (120 ng/mL). It was determined that the Xanax
the patient was taking was probably mixed with sulfonylureas. He was
subsequently discharged with a referral for drug rehab.

Figure 2: Patient’s Plasma Glucose Levels Over Time

• This patient satisfied Whipple’s triad: (1) hypoglycemia (plasma glucose
<50 mg/dL), 2) neuroglycopenic symptoms (i.e. weakness, dizziness,
confusion, blurred vision, difficulties with concentration), and 3) prompt
relief of symptoms following glucose administration, which raised the
clinical suspicion for insulinoma [3]. His insulin, proinsulin, and cpeptide levels suggested excessive endogenous insulin production.

• “Street Valium” or benzodiazepines intermixed with sulfonylureas have
previously been reported in case reports with supratherapeutic glyburide
levels of 1198 and 647 ng/mL [4]. To our knowledge, this is the first case
reported in Philadelphia.

Conclusion
• This case illustrates the potential for unsuspected substances,
particularly sulfonylureas, to contaminate street drugs.
• Clinicians should be aware of persistent hypoglycemia being a
complication of drug overdose and should perform workup as
appropriate.

Figure 1: NIH Drug Abuse Trends and Patterns in
Philadelphia – 2014 Report
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